Valentina Agredo-Delgado

Valentina Agredo-Delgado

Auto-generated profile, based on publicly available information

Valentina Agredo-Delgado

Metabolic Diseases Study Group, Department of Internal Medicine, Universidad del Cauca, Carrera 6 Nº 13N-50, Popayán 190001, Colombia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
HVHernando Vargas-uricoechea
Hernando Vargas-uricoechea
JNJuan Patricio Nogueira
Juan Patricio Nogueira
MPMaría Virginia Pinzón-Fernández
María Virginia Pinzón-Fernández
VAValentina Agredo-Delgado
Valentina Agredo-Delgado
HVHernando David Vargas-Sierra
Hernando David Vargas-Sierra
Vitamin B12 (B12) is necessary for the proper functioning of the central and peripheral nervous systems. Although there is no exact definition for B12 levels, a value of 200 pg/mL is compatible with deficiency, 200–299 pg/mL is considered borderline, and 300 pg/mL is considered normal. In population studies, the prevalence of B12 deficiency ranges between 2.9% and 35%. Furthermore, many medications, such as metformin [for type 2 diabetes mellitus (T2DM)], can cause B12 deficiency. The objectives of this study were to determine the population status of B12 in southwestern Colombia (and the status of B12 in subjects with T2DM). In the total population (participants with and without T2DM), the prevalence of B12 deficiency was 17.8%; that of borderline was 19.3%; and that of normal levels was 62.9%. The prevalence of deficiency increased with age and was significantly higher in those aged ≥60 years (p = 0.000). In T2DM subjects, the prevalence of deficiency was significantly higher concerning those without T2DM (p = 0.002) and was significantly higher in those who received >1 gm/day of metformin (p = 0.001). Thus, the prevalence of deficiency and borderline levels of B12 in our population was high, particularly in those >60 years of age. B12 deficiency was significantly higher in individuals with T2DM than in individuals without T2DM, especially among those receiving high doses of metformin.

1 May 2023 in Endocrine, Metabolic & Immune Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
HVHernando Vargas-uricoechea
Hernando Vargas-uricoechea
VAValentina Agredo-Delgado
Valentina Agredo-Delgado
HVHernando David Vargas-Sierra
Hernando David Vargas-Sierra
MPMaría Virginia Pinzón-Fernández
María Virginia Pinzón-Fernández
Background: The population prevalence of functional alterations and thyroid autoimmunity is high, and numerous genetic and environmental aspects have been described as triggering factors. Objectives: The objective of this study was to determine the prevalence of functional alterations and thyroid autoimmunity in an urban population of Colombia. Materials and methods: It is a cross-sectional, population-based study (n= 9,638) conducted on an urban population of Popayán-Cauca-Colombia between February 5th, 2018, to December 11th, 2021. The variables evaluated were thyrotropin (TSH), free T4 (FT4), and anti-thyroid antibodies (thyroid peroxidase antibodies: TPOAb, and thyroglobulin antibodies: TgAb). Results: TSH in men was significantly higher than in women. No differences were observed in the values of FT4, TPOAb, and TgAb (according to sex). The prevalence of normal thyroid function and subclinical hypothyroidism was significantly higher in men. The positivity of TPOAb and TgAb was 22.3% and 19.2%, respectively. TSH levels increased with age (both in men and in women). In participants with normal FT4 and negative TPOAb, the TSH was significantly higher. TSH was significantly higher in TPOAb-positive individuals and among those with TPOAb and TgAb positives, as well as in women with positive TPOAb and men with positive TPOAb and TgAb. Conclusion: In an urban population of Colombia, TSH was found to be higher than in populations of other geographical areas, especially in older individuals and in the presence of positive anti-thyroid antibodies, a high prevalence of functional alterations and thyroid autoimmunity was also found. These findings can be explained by excess iodine consumption and some environmental factors.

5 September 2022 in IATREIA
Verified
Journal Article
Open access
PDF file
MRMyriam Vanessa Rueda-Galvis
Myriam Vanessa Rueda-Galvis
ARAlejandro Román-González
Alejandro Román-González
VAValentina Agredo-Delgado
Valentina Agredo-Delgado
Los feocromocitomas y paragangliomas son neoplasias neuroendocrinas infrecuentes que pueden producir catecolaminas, y tienen una incidencia menor a un caso por millón de habitantes. Son histológicamente benignas y muestran mínimas diferencias respecto a sus contrapartes malignas; asimismo, son dos de las neoplasias humanas con mayor carga genética. La mutación más común es en la vía del complejo de la succinato deshidrogenasa (SDH), y de esta, una de las que menos se reportan son las variantes de la SDH subunidad A (SDHA). Se describe el caso de un paciente con feocromocitoma y paraganglioma asociados a una mutación en SDHA, y se señala su comportamiento y buena respuesta clínica al manejo quirúrgico y vigilancia activa.

1 March 2022 in Revista Colombiana de Endocrinología, Diabetes & Metabolismo
Verified
Journal Article
Open access
PDF file
CBCarlos E. Builes-Montaño
Carlos E. Builes-Montaño
MRMyriam V. Rueda-Galvis
Myriam V. Rueda-Galvis
MFMaría C. Fragozo-Ramos
María C. Fragozo-Ramos
VAValentina Agredo-Delgado
Valentina Agredo-Delgado
JZJulián Zea-Lopera
Julián Zea-Lopera
CMCarlos M. Muñetón-Peña
Carlos M. Muñetón-Peña
Introducción: La deficiencia de 17?-hidroxilasa / 17,20-liasa es causada por un defecto en el gen CYP17A1 que codifica una enzima que expresa tanto actividad 17?-hidroxilasa como 17,20-liasa en las glándulas suprarrenales y las gónadas. El fenotipo de esta condición es muy característico, pero lo pueden compartir otros defectos enzimáticos. La adecuada relación genotipo-fenotipo es importante para el correcto diagnóstico, enfocar el tratamiento y la consejería a los pacientes. Objetivo del caso: Reportar por primera vez una variante genética potencialmente relacionada con una hiperplasia adrenal congénita en una paciente con un fenotipo compatible con una deficiencia de 17?-hidroxilasa y la 17,20-liasa. Presentación del caso: Se presenta el caso de una mujer que consultó por infantilismo sexual y amenorrea primaria en presencia de cariotipo 46XX. Durante su evolución cursó con hipertensión e hipokalemia que condujo a la sospecha diagnóstica de una hiperplasia adrenal congénita (HAC). El estudio genético reveló una mutación de cambio de sentido erróneo, homocigota, en el exón 8, c.1250 T>C; p. Phe417Ser del gen de la CYP17A1. Se ha demostrado previamente que mutaciones en esta localización suprimen las actividades 17?-hidroxilasa y la 17,20-liasa lo que explica el fenotípico clínico observado. Reportamos por primera vez en el mundo la mutación de cambio de sentido erróneo, c.1250 T>C; p. Phe417Ser, en el gen CYP17A1, relacionada con la HAC. Conclusión: Los análisis genéticos en todos los pacientes con HAC son necesarios para definir la frecuencia de esta y otras mutaciones en la población colombiana y relacionar el fenotipo de la enfermedad con su genotipo.

11 February 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
HVHernando Vargas-Uricoechea
Hernando Vargas-Uricoechea
APAlejandro Alberto Castellanos Pinedo
Alejandro Alberto Castellanos Pinedo
KUKaren Urrego-Noguera
Karen Urrego-Noguera
MPMaría Virginia Pinzón-Fernández
María Virginia Pinzón-Fernández
IMIvonne A. Meza-Cabrera
Ivonne A. Meza-Cabrera
VAValentina Agredo-Delgado
Valentina Agredo-Delgado
Background/Objectives: It has been suggested that vitamin D and magnesium levels appear to be associated with an increased risk of functional disorders and/or autoimmune thyroid diseases (AITD). In this study, our objective was to evaluate whether 25OH vitamin D (25OH Vit-D) and/or magnesium (Mg) levels are associated with an increased risk of AITD and/or thyroid dysfunction. Methods: A population-based case-control study was conducted (n = 1028) (cases: n = 514; controls: n = 514). Blood concentrations of 25OH Vit-D, Mg, TSH, FT4, FT3, and thyroid autoantibodies (TPOAb, TgAb, and TRAb) were determined in the study participants. Results: The prevalence of goiter, hypothyroidism, and thyroid autoantibody positivity was significantly higher in women (among cases). No differences were found in the prevalence of other thyroid disorders or thyroid antibody positivity (among cases) based on sex or age. The prevalence of thyroid antibody positivity (specifically TPOAb and/or TgAb) was significantly higher in cases with 25OH Vit-D and/or Mg deficiency. The 25OH Vit-D level that best discriminated the highest frequency of AITD was 23.5 ng/mL [AUC: 0.665 (95% CI: 0.636–0.694, p< 0.001)]; while for Mg it was 1.8 mg/dL [AUC: 0.697 (95% CI: 0.668–0.725, p< 0.001)]. Conclusions: The results of our study suggest that low levels of 25OH Vit-D and/or Mg are associated with an increased risk of goiter, hypothyroidism, and AITD.

3 January 2023 in Medicina y Laboratorio
Verified
Journal Article
Open access
PDF file
AVAlejandro Vélez-Hoyos
Alejandro Vélez-Hoyos
VAValentina Agredo-Delgado
Valentina Agredo-Delgado
AAAníbal Ariza-Gutiérrez
Aníbal Ariza-Gutiérrez
CDCarlos Simón Duque-Fisher
Carlos Simón Duque-Fisher
JDJuan Duenas
Juan Duenas
ARAlejandro Román-González
Alejandro Román-González
Las lesiones metastásicas representan hasta un 3 % de los tumores malignos de la glándula tiroides. La mayoría de los casos se originan de tumores de células renales y de pulmón. El abordaje diagnóstico implica una alta sospecha clínica en pacientes con primarios conocidos, sin embargo, puede ser la manifestación inicial de una enfermedad maligna extensa no diagnosticada hasta en un 20 % a 40 % de los pacientes. La biopsia por aguja fina ha demostrado buen rendimiento para el diagnóstico de los nódulos metastásicos. El pronóstico y la opción del tratamiento quirúrgico dependen del control local del primario y del estado de la enfermedad sistémica asociada, por lo tanto, debe ser individualizado. Por lo general, hasta un 80 % de los pacientes con compromiso de la tiroides tienen enfermedad metastásica multiorgánica, y la intención del tratamiento quirúrgico es con fines paliativos para prevenir las complicaciones derivadas de la extensión local de la enfermedad a las estructuras del tracto aerodigestivo superior en el cuello. Se presenta a continuación, una serie de seis casos de pacientes con lesiones metastásicas a glándula tiroides con primarios en riñón, mama y de melanomas.